AICAR Research Reference

Catalog classification, reference sizes, lab math links, and source-backed data. Educational use only — not medical advice.

Researched for: AMPK signaling and metabolic adaptation

Metabolic Research compound LyophilizedPowderLiquid verified

Also known as: Acadesine, AICA riboside

Quick Facts

Reference Sizes
50 mg, 100 mg, 1 g
Storage
Supplier specifications commonly use -20 deg C for solid material; solution stability is formulation-specific and should follow the study protocol
Solubility
Freely water-soluble (>=52.9 mg/mL); also soluble in DMSO (>=12.9 mg/mL); use fresh solutions

Catalog Description

AICAR (5-aminoimidazole-4-carboxamide ribonucleoside, acadesine) is phosphorylated intracellularly to ZMP, an AMP-mimetic that allosterically activates AMPK, driving insulin-independent glucose uptake, increased fatty-acid oxidation, suppressed hepatic gluconeogenesis/lipogenesis, and mTORC1 inhibition. A landmark 2008 Cell study (Narkar, Downes et al.) found AICAR alone increased running endurance by 44% in sedentary mice via AMPK-PPARdelta pathway activation - the widely cited 'exercise mimetic' finding - but no equivalent human performance data exists. Acadesine's most extensive human clinical data comes from a different context: cardiovascular protection during/after cardiac surgery, studied in Phase 3 trials in the 1990s (meta-analysis of 5 international RCTs, 4,043 patients) and Phase I/II oncology trials in the 2000s; none resulted in regulatory approval for any indication.

Catalog descriptions reflect research context only. Not a medical claim or treatment recommendation.

Research Profile

Half-Life
Short and route-dependent; published human studies do not support one universal half-life value
Onset
Endurance effects reported in mouse studies over the study duration; human trials assessed cardiac-protection endpoints acutely (surgical setting)
Administration Routes (Research)
IV (human studies)IP (animal studies)In vitro

Reported Research Effects

Reported Research Side Effects

Data source: Narkar/Downes 2008 (Cell); cardiac-surgery RCT meta-analysis; oncology Phase I/II trials

Reflects preclinical/research literature context only. Not a medical claim, dosing instruction, or treatment recommendation.

Research Protocols Reported in the Literature

Research Notes

Also sold as liquid solution by some vendors in addition to lyophilized/bulk powder. Liquid typically sold in 30 mL bottles.

Supplementary research context only. Not medical advice or a treatment recommendation.

Sources

AMPK and PPAR-delta agonists are exercise mimetics — Cell
https://doi.org/10.1016/j.cell.2008.06.051
AICAr, a Widely Used AMPK Activator with Important AMPK-Independent Effects: A Systematic Review — Cells (MDPI)
https://www.mdpi.com/2073-4409/10/5/1095

Suggest a community source

Found a relevant Reddit or forum thread about this compound? Suggest it below. Every suggestion is reviewed by an editor before it appears -- nothing is published automatically.

Related Research Tools

Research Use Only. All content is for educational and research reference only. Not medical advice, a treatment recommendation, or guidance on human use. Compounds are not FDA-approved drugs unless specifically noted.

Scroll to Top